Reference
McQuade JL, et al. Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab JAMA Oncology : 14 Dec 2022. Available from: URL: https://doi.org/10.1001/jamaoncol.2022.5409
Rights and permissions
About this article
Cite this article
Obesity increases risk of irAEs in patients receiving nivolumab. Reactions Weekly 1937, 11 (2022). https://doi.org/10.1007/s40278-022-29691-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-29691-0